최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.31 no.3, 2010년, pp.631 - 649
박윤식 (대구한의대학교 한의과대학 신계내과학교실) , 윤경민 (대구한의대학교 한의과대학 신계내과학교실) , 임은영 (대구한의대학교 한의과대학 신계내과학교실) , 신현철 (대구한의대학교 한의과대학 신계내과학교실) , 강석봉 (대구한의대학교 한의과대학 신계내과학교실)
Objective : The object of this study was to observe the effects of aqueous extracts of Chunglijagam-tang(CLJGT), which has traditionally been used in Korean medicine for treating various diseases, on streptozotocin(STZ)-induced rat diabetes and related complications: diabetic nephropathy, hepatopath...
두호경. 동의신계학. 서울: 동양의학연구원; 1993, p. 1173-8.
2009.3.13. 보건복지부. 2007년도 보건복지통계연보. 2007. Available at http://www.mohw.go.kr /user.tdf?auser.tbdata.BoardApp&c2001&bo ard_idgp_tb_data&skinp_new_m2_co mmon&bunr_code310&mcP_03_05_02
E Braunwald, A Fauci, D. Kasper, S. Hauser, D. Longo, J. Jameson. 해리슨 내과학. 15th. 서울: MIP; 2003, p. 2178-9, 2188.
朱震亨. 丹溪心法. 서울: 대성문화사; 1982, p. 503-9.
공정현. 만병회춘, 香港: 인민위생출판사; 1980, p. 201.
林?琴. 類證治裁, 北京: 의풍 族風文化社; 1985, p. 77, 1839.
許浚. 標點,索引東醫寶鑑. 東醫文獻硏究室再編輯. 서울: 法仁文化社; 2005, p. 337.
심범상, 강희, 김성훈, 안규석. 淸離滋坎湯에 의한 면역기능 연구. 동의병리학회지. 2001;15:693-6.
조경삼, 김시영, 박재경, 최성훈, 정세영, 윤희중. 複合韓藥劑淸籬滋坎湯의 抗癌效果및 作用機轉糾明. 경희대학교 동서의학연구소 국제학술대회 논문집. 1999:231-43.
Institute of Laboratory Animal Resources (Commission on Life Sciences, National Research Council, USA). Guide for the care and use of laboratory animals. 7. Washington, D.C.: National Academic press; 1996, p. 1-118.
Kavutcu M, Canbolat O, Ozturk S, Olcay E, Ulutepe S, Ekinci C, Gokhun IH, Durak I. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C. Nephron. 1996;72:269-74.
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
Draper HH, Hadley M. Methods in Enzymology. New York: Academic Press; 1900, p. 421.
Eyer P, Podhradsky D. Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal Biochem. 1986;153:57-66.
Quine SD, Raghu PS. Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in STZ-induced diabetic liver, kidney and heart. Pharmacol Rep. 2005;57:610-5.
Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs. 2001;15:465-89.
Lorenz D, Mennicke WH. Elimination of drugs in cholecystectomized patients. Studies with silymarin in patients with extrahepatic complications. Methods Find Exp Clin Pharmacol. 1981;3: 103-6.
Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term(12 months) treatment with an anti-oxidant drug(silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol. 1997;26:871-9.
Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001 ;61:2035-63.
Lirussi F, Beccarello A, Zanette G, De Monte A, Donadon V, Velussi M, Crepaldi G. Silybin -beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. Diabetes Nutr Metab. 2002;15:222-31.
Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M. The efficacy of Silybum marianum(L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006;20:1036-9.
Guerrero-Analco JA, Hersch-Martinez P, Pedraza -Chaverri J, Navarrete A, Mata R. Antihyperglycemic effect of constituents from Hintonia standleyana in STZ-induced diabetic rats. Planta Med. 2005 ;71:1099-105.
Uchiyama S, Yamaguchi M. Oral administration of beta-cryptoxanthin prevents bone loss in STZ-diabetic rats in vivo. Biol Pharm Bull. 2005;28:1766-9.
Cohen MP, Clements RS, Cohen JA, Shearman CW. Prevention of decline in renal function in the diabetic db/db mouse. Diabetologia. 1996 ;39:270-4.
Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol. 2002;17:20-9.
Sato S, Yamate J, Hori Y, Hatai A, Nozawa M, Sagai M. Protective effect of polyphenol-polyphenolcontaining azuki bean(Vigna angularis) seed coats on the renal cortex in STZ-induced diabetic rats. J Nutr Biochem. 2005;16:547-53.
Sodikoff CH. Laboratory profiles of small animal diseases. A guide to laboratory diagnosis. 2nd ed., St. Louise: Mosby; 1995, p. 1-36.
Imaeda A, Kaneko T, Aoki T, Kondo Y, Nakamura N, Nagase H, Yoshikawa T. Antioxidative effects of fluvastatin and its metabolites against DNA damage in STZtreated mice. Food Chem Toxicol. 2002;40 :1415-22.
Clark TA, Heyliger CE, Edel AL, Goel DP, Pierce GN. Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in STZ-induced diabetic rats. Metabolism. 2004;53:1145-51.
Ducobu J. Dyslipidaemia and diabetes mellitus. Rev Med Liege. 2005;60:578-85.
Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol. 2005;97:227-30.
Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004;148:635-40.
Forrester JS, Makkar R, Shah PK. Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. Circulation. 2005;111 :1847-54.
Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, Chayama K, Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005;37 :39-43.
Cheng JW. Rosuvastatin in the management of hyperlipidemia. Clin Ther. 2004;26:1368-87.
Pirat B, Korkmaz ME, Eroglu S, Tayfun E, Yildirir A, Ulucam M, Ozin B, Muderrisoglu H. The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels. Anadolu Kardiyol Derg. 2004;4:318-22.
Zdrenghea D, Gligor E, Ossian V, Pop D. The effect of simvastatin associated with ranitidine and alcohol upon serum lipids. Rom J Intern Med. 2004;42:143-8.
Garg MC, Singh KP, Bansal DD. Effect of vitamin C supplementation on oxidative stress in experimental diabetes. Indian J Exp Biol. 1997;35:264-6.
Collier A, Wilson R, Bradley H, Thomson JA, Small M. Free radical activity in type 2 diabetes. Diabet Med. 1990;7:27-30.
Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med. 1992;9:297-9.
Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-67.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.